Sirukumab (CNTO-136) 是一种人源化单克隆抗IL6(Interleukin Related) IgG1κ 抗体。Sirukumab 具有用于活动性狼疮性肾炎研究的潜力。
| 生物活性 | Sirukumab (CNTO-136) is a humanized monoclonal anti-IL6(Interleukin Related) IgG1κ antibody. Sirukumab has the potential for active lupus nephritis research[1]. |
| 分子量 | |
| CAS 号 | |
| 中文名称 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
